390 related articles for article (PubMed ID: 11302864)
1. Incidence of clinically manifest ulcers and their complications in patients with rheumatoid arthritis.
Steen KS; Lems WF; Aertsen J; Bezemer D; Dijkmans BA
Ann Rheum Dis; 2001 May; 60(5):443-7. PubMed ID: 11302864
[TBL] [Abstract][Full Text] [Related]
2. Decreasing incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid arthritis.
Steen KS; Nurmohamed MT; Visman I; Heijerman M; Boers M; Dijkmans BA; Lems WF
Ann Rheum Dis; 2008 Feb; 67(2):256-9. PubMed ID: 17604285
[TBL] [Abstract][Full Text] [Related]
3. An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs.
Cheatum DE; Arvanitakis C; Gumpel M; Stead H; Geis GS
Clin Ther; 1999 Jun; 21(6):992-1003. PubMed ID: 10440623
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.
La Corte R; Caselli M; Castellino G; Bajocchi G; Trotta F
Drug Saf; 1999 Jun; 20(6):527-43. PubMed ID: 10392669
[TBL] [Abstract][Full Text] [Related]
5. Prevention of NSAID-induced gastroduodenal ulcers.
Rostom A; Dube C; Wells G; Tugwell P; Welch V; Jolicoeur E; McGowan J
Cochrane Database Syst Rev; 2002; (4):CD002296. PubMed ID: 12519573
[TBL] [Abstract][Full Text] [Related]
6. Prevention of NSAID-induced gastroduodenal ulcers.
Rostom A; Wells G; Tugwell P; Welch V; Dube C; McGowan J
Cochrane Database Syst Rev; 2000; (4):CD002296. PubMed ID: 11034748
[TBL] [Abstract][Full Text] [Related]
7. Prevention of NSAID-gastropathy.
Ardizzone S; Bianchi Porro G
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of NSAID induced gastroduodenal ulcers].
Hansen JM; Bytzer P
Ugeskr Laeger; 2001 Oct; 163(44):6103-5. PubMed ID: 11715151
[TBL] [Abstract][Full Text] [Related]
9. [Present position in the prevention and therapy of NSAID-induced ulcers].
Lehmann FS; Beglinger C
Schweiz Med Wochenschr; 1999 Jul; 129(29-30):1073-80. PubMed ID: 10464910
[TBL] [Abstract][Full Text] [Related]
10. Prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal mucosal injury: risk factors for serious complications.
Koch M; Dezi A; Tarquini M; Capurso L
Dig Liver Dis; 2000 Mar; 32(2):138-51. PubMed ID: 10975790
[TBL] [Abstract][Full Text] [Related]
11. Prevention of chronic NSAID induced upper gastrointestinal toxicity.
Rostom A; Wells G; Tugwell P; Welch V; Dube C; McGowan J
Cochrane Database Syst Rev; 2000; 2002(3):CD002296. PubMed ID: 10908548
[TBL] [Abstract][Full Text] [Related]
12. Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal anti-inflammatory drugs in Japan.
Ishikawa S; Inaba T; Mizuno M; Okada H; Kuwaki K; Kuzume T; Yokota H; Fukuda Y; Takeda K; Nagano H; Wato M; Kawai K
Acta Med Okayama; 2008 Feb; 62(1):29-36. PubMed ID: 18323869
[TBL] [Abstract][Full Text] [Related]
13. Who needs prophylaxis of nonsteroidal anti-inflammatory drug-induced ulcers and what is optimal prophylaxis?
Goldstein JL
Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S11-5. PubMed ID: 10929893
[TBL] [Abstract][Full Text] [Related]
14. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
[TBL] [Abstract][Full Text] [Related]
15. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D
J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558
[TBL] [Abstract][Full Text] [Related]
16. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration.
Armstrong CP; Blower AL
Gut; 1987 May; 28(5):527-32. PubMed ID: 3596334
[TBL] [Abstract][Full Text] [Related]
17. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors.
Laine L
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):25-32. PubMed ID: 12528071
[TBL] [Abstract][Full Text] [Related]
18. [Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors].
Karateev AE; Nasonova VA
Ter Arkh; 2008; 80(5):62-6. PubMed ID: 18590118
[TBL] [Abstract][Full Text] [Related]
19. Non-steroidal anti-inflammatory drugs (NSAID) cause gastrointestinal ulcers mainly in Helicobacter pylori carriers.
Publig W; Wüstinger C; Zandl C
Wien Klin Wochenschr; 1994; 106(9):276-9. PubMed ID: 8023522
[TBL] [Abstract][Full Text] [Related]
20. Complications of nonsteroidal antiiflammatory drug gastropathy and use of gastric cytoprotection: experience at a tertiary care health center.
Bakowsky VS; Hanly JG
J Rheumatol; 1999 Jul; 26(7):1557-63. PubMed ID: 10405945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
